{{drugbox
| Watchedfields = changed
| drug_name = Dopamine
| verifiedrevid = 595793408
| image = Dopamine2.svg
| alt =
| image2 = Dopamine 3D ball.png
| alt2 =
| IUPAC_name=4-(2-Aminoethyl)benzene-1,2-diol
| synonyms=2-(3,4-Dihydroxyphenyl)ethylamine;  3,4-Dihydroxyphenethylamine;  3-hydroxytyramine; DA; Intropin; Revivan; Oxytyramine; Prolactin inhibiting factor; Prolactin inhibiting hormone

<!--Clinical data-->
| tradename = Intropin、Dopastat、Revimine等
| Drugs.com = {{Drugs.com|monograph|dopamine-hydrochloride}}
| pregnancy_US = C
| legal_AU = 
| legal_CA = 
| legal_UK = 
| legal_US = 
| licence_US = Dopamine
| legal_status = Rx-only
| routes_of_administration= [[靜脈注射|靜脈注射]]

<!--Physiological data-->
| source_tissues = [[黑質|黑質]]、[[腹側被蓋區|腹側被蓋區]]等區域
| target_tissues = System-wide
| receptors = {{tsl|en|Dopamine receptor D1|多巴胺受體D1|D<sub>1</sub>}}、[[多巴胺受體D2|D<sub>2</sub>]]、{{tsl|en|Dopamine receptor D3|多巴胺受體D3|D<sub>3</sub>}}, [[多巴胺受体D4|D<sub>4</sub>]]、{{tsl|en|Dopamine receptor D5|多巴胺受體D5|D<sub>5</sub>}}、{{tsl|en|TAAR1|TAAR1}}<ref name="DA IUPHAR">{{cite web|title=Dopamine: Biological activity|url=http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=940|work=IUPHAR/BPS guide to pharmacology|publisher=International Union of Basic and Clinical Pharmacology|accessdate=2016-01-29|deadurl=no|archiveurl=https://web.archive.org/web/20160205041409/http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=940|archivedate=2016-02-05|df=}}</ref>
| agonists = 直接受體激動劑：{{tsl|en|apomorphine|阿樸嗎啡}}、[[溴隱亭|溴隱亭]]<br />{{tsl|en|Indirect agonist|間接受體激動劑|激動劑}}：[[可卡因|可卡因]]、[[苯丙胺|苯丙胺]]
| antagonists = [[抗精神病藥|抗精神病藥]]、[[metoclopramide|metoclopramide]]、[[多潘立酮|多潘立酮]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = [[单胺氧化酶|MAO]]、[[儿茶酚-O-甲基转移酶|COMT]]<ref name="DA IUPHAR" />、{{tsl|en|aldehyde dehydrogenase|醛脫氫酶|ALDH}}、[[多巴胺β羟化酶|DBH]]、{{tsl|en|Monoamine oxidase A|單胺氧化酶A|MAO-A}}、{{tsl|en|Monoamine oxidase B|單胺氧化酶B|MAO-B}}、[[儿茶酚-O-甲基转移酶|COMT]]
| elimination_half-life = 
| excretion = 腎臟

<!--Identifiers-->
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = VTD58H1Z2X
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = VYFYYTLLBUKUHU-UHFFFAOYSA-N
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number =51-61-6
| CAS_supplemental ={{CAS|62-31-7}} (hydrochloride)
| PubChem=681
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 59
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 661
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07870
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00988
| IUPHAR_ligand = 940
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 18243
| SMILES = c1cc(c(cc1CCN)O)O
| ATC_prefix = C01
| ATC_suffix = CA04

<!--Chemical data-->
| C=8 | H=11 | N=1 | O=2
| molecular_weight = 153.18 g/mol
| density = 1.26
| boiling_point = 
| boiling_notes = 降解
| melting_point = 128
| melting_notes =
| solubility = <!--60.0 g/100 ml-->
}}
<!-- Definition and medical uses -->
{{medical}}
'''多巴胺'''（Dopamine）藥品名稱有'''恩得品'''（Intropin）等，是常用來治療[[休克|休克]]、有導致其他症狀的[[心跳過缓|心跳過缓]]的藥物<ref name=AHSP2016/>，若[[心搏停止|心搏停止]]，又沒有[[肾上腺素|肾上腺素]]的情形下，也可用多巴胺治療<ref name=AHSP2016>{{cite web|title=Dopamine Hydrochloride|url=https://www.drugs.com/monograph/dopamine-hydrochloride.html|website=drugs.com|publisher=American Society of Health-System Pharmacists|accessdate=2016-07-15|date=2016-06-29|deadurl=no|archiveurl=https://web.archive.org/web/20160914161247/https://www.drugs.com/monograph/dopamine-hydrochloride.html|archivedate=2016-09-14|df=}}</ref>。多巴胺也是治療[[嬰兒|嬰兒]]嚴重[[低血壓|低血壓]]的首選藥物<ref name=Bh2016>{{cite journal|last1=Bhayat|first1=SI|last2=Gowda|first2=HM|last3=Eisenhut|first3=M|title=Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence.|journal=World journal of clinical pediatrics|date=2016-05-08|volume=5|issue=2|pages=212–22|pmid=27170932|doi=10.5409/wjcp.v5.i2.212|pmc=4857235}}</ref>。若是兒童低血壓，一般會用[[腎上腺素|腎上腺素]]或{{le|正腎上腺素 (藥物)|Norepinephrine (medication)|正腎上腺素}}治療，成人則會用正腎上腺素治療<ref name=De2012>{{cite journal|last1=De Backer|first1=D|last2=Aldecoa|first2=C|last3=Njimi|first3=H|last4=Vincent|first4=JL|title=Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*.|journal=Critical Care Medicine|date=March 2012|volume=40|issue=3|pages=725–30|pmid=22036860|doi=10.1097/ccm.0b013e31823778ee}}</ref><ref name=Del2012>{{cite journal|last1=Dellinger|first1=RP|last2=Levy|first2=MM|last3=Rhodes|first3=A|last4=Annane|first4=D|last5=Gerlach|first5=H|last6=Opal|first6=SM|last7=Sevransky|first7=JE|last8=Sprung|first8=CL|last9=Douglas|first9=IS|last10=Jaeschke|first10=R|last11=Osborn|first11=TM|last12=Nunnally|first12=ME|last13=Townsend|first13=SR|last14=Reinhart|first14=K|last15=Kleinpell|first15=RM|last16=Angus|first16=DC|last17=Deutschman|first17=CS|last18=Machado|first18=FR|last19=Rubenfeld|first19=GD|last20=Webb|first20=SA|last21=Beale|first21=RJ|last22=Vincent|first22=JL|last23=Moreno|first23=R|last24=Surviving Sepsis Campaign Guidelines Committee including the Pediatric|first24=Subgroup|title=Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.|journal=Critical Care Medicine|date=February 2013|volume=41|issue=2|pages=580–637|pmid=23353941|doi=10.1097/CCM.0b013e31827e83af}}</ref>。多巴胺可用[[靜脈注射|靜脈注射]]或{{le|骨內注射|Intraosseous infusion}}的方式持續給藥<ref name=AHSP2016/>，藥效一般會在五分鐘後開始<ref name=AHSP2016/>，之後可以適度增加劑量以達到最佳藥效<ref name=AHSP2016/>。

<!-- Side effects -->
常見的[[副作用|副作用]]包括[[腎功能|腎功能]]惡化、[[心律不整|心律不整]]、[[心绞痛|心绞痛]]、[[呕吐|呕吐]]、[[頭痛|頭痛]]、焦慮<ref name=AHSP2016/>，若{{le|外滲|Extravasation (intravenous)}}到血管附近的軟組織，可能會有局部的{{le|組織壞死|tissue necrosis}}<ref name=AHSP2016/>，此時可以試著用{{le|酚妥拉明|phentolamine}}來降低風險<ref name=AHSP2016/>。還不確定在[[妊娠|妊娠]]及[[母乳哺育|母乳哺育]]中使用多巴胺的安全性<ref name=AHSP2016/>。低劑量的多巴胺會觸發{{le|多巴胺受體|dopamine receptor}}及{{le|β1-腎上腺素能受體|β1-adrenergic receptor}}，高劑量的多巴胺則會透過{{le|α-腎上腺素能受體|α-adrenergic receptor}}作用<ref name=AHSP2016/>。

<!-- Society and culture -->
多巴胺最早是在1910年由George Barger及James Ewens在英國實驗室所製備<ref name="pmid18781671">{{cite journal | vauthors = Fahn S | title = The history of dopamine and levodopa in the treatment of Parkinson's disease | journal = Movement Disorders | volume = 23 Suppl 3 | issue = | pages = S497–508 | year = 2008 | pmid = 18781671 | doi = 10.1002/mds.22028|quote=According to Hornykiewicz,6 dopamine was first synthesized by George Barger and James Ewens in 1910 at the Wellcome labs in London, England.}}</ref>，是[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]中的藥物，於[[醫療系統|醫療系統]]所需最有效及安全的藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=2016-12-08|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=2016-12-13|df=}}</ref>。
2014年在[[開發中國家|開發中國家]]中，400mg的多巴胺藥價在美金0.28元至0.60元之間<ref name=ERC2014>{{cite web|title=Dopamine|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=DOP40A&s_year=2014&year=2014&str=40%20mg%2Fml&desc=Dopamine%20HCl&pack=new&frm=AMPOULE&rte=INJ&class_code2=12%2E4%2E&supplement=&class_name=%2812%2E4%2E%29Medicines%20used%20in%20heart%20failure%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=2015-12-05}}{{dead link|date=2018年5月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>。人體內也有自然產生的[[多巴胺|多巴胺]]，類似[[激素|激素]]一樣是[[神經遞質|神經遞質]]<ref>{{cite book|last1=Millar|first1=Thomas|title=Biochemistry explained : a practical guide to learning biochemistry|date=2002|publisher=Routledge|location=London|isbn=9780415299411|page=40|url=https://books.google.ca/books?id=WywxhvLh1R8C&pg=PA40|deadurl=no|archiveurl=https://web.archive.org/web/20160815234209/https://books.google.ca/books?id=WywxhvLh1R8C&pg=PA40|archivedate=2016-08-15|df=}}</ref>。

==參考資料==
{{Reflist|32em}}

{{Cardiac stimulants excluding cardiac glycosides}}
<!--{{Dopaminergics}}-->

[[Category:多巴胺激动剂|Category:多巴胺激动剂]]
[[Category:作用于心血管系统的药物|Category:作用于心血管系统的药物]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]